Centeon Pharma to produce low-cost insulin using Lilly ingredients
A deal was signed between Centeon Pharma and Eli Lilly & Co to import crystals The factory in Gazipur, Konapara is expected to go into production in 2025 Centeon Pharma aims at delivering insulin to 1mn diabetic patients by 2025 Once produced, it is possible to deliver insulin at 40% lower price, says official In Bangladesh, around 60% diabetes patients are under
Source: tbsnews.net
